Diabetes Drug Might Help Detect and Treat Alzheimer’s Disease – Pharmaceutical Processing
As the number of patients with Alzheimer’s disease (AD) rapidly increases, new treatments as well as blood tests that are simple and can be easily performed in a doctor’s office to diagnose are urgently needed. A new study has found treatment with the diabetes drug amylin (or pramlintide) safely improves learning and memory function in AD patients and reduces the AD pathology in their brains.
